A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 107,790 shares of ABT stock, worth $12.3 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
107,790
Previous 22,840 371.94%
Holding current value
$12.3 Million
Previous $2.6 Million 331.6%
% of portfolio
0.5%
Previous 0.36%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$100.73 - $112.44 $8.56 Million - $9.55 Million
84,950 Added 371.94%
107,790 $11.2 Million
Q1 2024

Apr 11, 2024

BUY
$109.52 - $120.96 $958,409 - $1.06 Million
8,751 Added 62.11%
22,840 $2.6 Million
Q4 2023

Jan 08, 2024

BUY
$90.19 - $110.4 $796,107 - $974,500
8,827 Added 167.75%
14,089 $1.55 Million
Q3 2023

Oct 06, 2023

SELL
$95.53 - $114.62 $4,489 - $5,387
-47 Reduced 0.89%
5,262 $509,000
Q2 2023

Jul 05, 2023

BUY
$100.78 - $112.29 $201 - $224
2 Added 0.04%
5,309 $578,000
Q1 2023

Apr 05, 2023

SELL
$96.86 - $114.01 $2,905 - $3,420
-30 Reduced 0.56%
5,307 $537,000
Q4 2022

Jan 10, 2023

SELL
$95.06 - $111.52 $2,376 - $2,788
-25 Reduced 0.47%
5,337 $0
Q3 2022

Oct 11, 2022

BUY
$96.76 - $112.03 $290 - $336
3 Added 0.06%
5,362 $519,000
Q2 2022

Jul 06, 2022

BUY
$102.07 - $123.37 $87,984 - $106,344
862 Added 19.17%
5,359 $582,000
Q1 2022

Apr 26, 2022

BUY
$114.02 - $139.04 $15,620 - $19,048
137 Added 3.14%
4,497 $532,000
Q1 2022

Apr 11, 2022

BUY
$114.02 - $139.04 $282,427 - $344,402
2,477 Added 131.55%
4,360 $516,000
Q4 2021

Jan 12, 2022

SELL
$115.53 - $141.46 $46,558 - $57,008
-403 Reduced 17.63%
1,883 $265,000
Q3 2021

Oct 07, 2021

BUY
$116.66 - $129.06 $233 - $258
2 Added 0.09%
2,286 $270,000
Q2 2021

Jul 12, 2021

BUY
$105.79 - $124.53 $10,790 - $12,702
102 Added 4.67%
2,284 $265,000
Q1 2021

Apr 09, 2021

BUY
$108.84 - $128.23 $237,488 - $279,797
2,182 New
2,182 $262,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.